Home › Funds › Marshall Wace › XRAY
Marshall Wace position in XRAY
DENTSPLY SIRONA INC · Health Care
Latest position (Q2 2026)3.80M sh
Reported value held$40.32M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 158.15K | $9.18M | New |
| Q4 2021 | 341.70K | $19.06M | Add |
| Q4 2023 | 1.15M | $40.82M | New |
| Q1 2024 | 2.13M | $70.85M | Add |
| Q4 2024 | 829.95K | $15.75M | New |
| Q1 2025 | 810.22K | $12.10M | Reduce |
| Q3 2025 | 197.51K | $2.51M | New |
| Q4 2025 | 2.24M | $25.57M | Add |
| Q1 2026 | 4.51M | $52.30M | Add |
| Q2 2026 | 3.80M | $40.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding XRAY
- BlackRock Inc 26.71M sh · $283.40M · Q2 2026
- Vanguard Group 21.86M sh · $249.87M · Q4 2025
- AQR Capital Management 10.46M sh · $110.18M · Q2 2026
- Lazard Asset Management 8.27M sh · $87.74M · Q2 2026
- Geode Capital Management 5.65M sh · $59.96M · Q2 2026
- D. E. Shaw & Co 2.99M sh · $31.69M · Q2 2026
- Bank of America Corp 2.92M sh · $31.00M · Q2 2026
- Northern Trust Corp 2.59M sh · $27.49M · Q2 2026
- Charles Schwab Investment Management 2.52M sh · $26.69M · Q2 2026
- Morgan Stanley 2.00M sh · $21.27M · Q2 2026
- UBS Group AG 1.97M sh · $20.87M · Q2 2026